Advanced search
Publication Cover
Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
Revue canadienne des soins respiratoires et critiques et de la médecine du sommeil
Volume 7, 2023 - Issue 5
Submit an article Journal homepage
5,247
Views
1
CrossRef citations to date
0
Altmetric
CTS Guidelines and Position Papers

Canadian Thoracic Society Position Statement on Climate Change and Choice of Inhalers for Patients with Respiratory Disease

Samir Guptaa Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Unity Health, Toronto, Ontario, Canada;b Division of Respirology, Department of Medicine, University of Toronto, Toronto, Ontario, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7307-6247View further author information
ORCID Icon,
Simon Couillardc Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Quebec, CanadaORCID Iconhttps://orcid.org/0000-0002-4057-6886View further author information
ORCID Icon,
Geneviève Digbyd Department of Medicine, Division of Respirology, Queen’s University, Kingston, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0002-1858-0387View further author information
ORCID Icon,
Sze Man Tsee Faculté de Médecine, Université de Montréal, Montréal, Quebec, Canada;f Division of Respiratory Medicine, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Montréal, Québec, CanadaORCID Iconhttps://orcid.org/0000-0002-0295-0064View further author information
ORCID Icon,
Samantha Greeng St. Michael’s Hospital, Unity Health Toronto and Department of Family & Community Medicine, University of Toronto, Toronto, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0003-4342-2070View further author information
ORCID Icon,
Raymond Aceronh Faculty of Nursing, University of Alberta, Edmonton, Alberta, CanadaView further author information
,
Chris Carlsteni Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaView further author information
,
Jill Hubickj Lung Saskatchewan, Saskatoon, Saskatchewan, CanadaView further author information
&
Erika Penzk Division of Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, CanadaORCID Iconhttps://orcid.org/0000-0003-2610-8450View further author information
ORCID Icon show all
Pages 232-239 | Received 13 Apr 2023, Accepted 22 Aug 2023, Published online: 11 Oct 2023

References

  • Costello A, Abbas M, Allen A, et al. Managing the health effects of climate change: Lancet and University College London Institute for Global Health Commission. Lancet. 2009;373(9676):1693–1733. doi:10.1016/S0140-6736(09)60935-1.
  • Pacheco SE, Guidos-Fogelbach G, Annesi-Maesano I, et al. Climate change and global issues in allergy and immunology. J Allergy Clin Immunol. 2021;148(6):1366–1377. doi:10.1016/j.jaci.2021.10.011.
  • Vicedo-Cabrera AM, Scovronick N, Sera F, et al. The burden of heat-related mortality attributable to recent human-induced climate change. Nat Clim Chang. 2021;11(6):492–500. doi:10.1038/s41558-021-01058-x.
  • Jain P, Castellanos-Acuna D, Coogan SCP, Abatzoglou JT, Flannigan MD. Observed increases in extreme fire weather driven by atmospheric humidity and temperature. Nat Clim Chang. 2022;12(1):63–70. doi:10.1038/s41558-021-01224-1.
  • Tiotiu AI, Novakova P, Nedeva D, et al. Impact of air pollution on asthma outcomes. IJERPH. 2020;17(17):6212. doi:10.3390/ijerph17176212.
  • Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114–1121. doi:10.1164/rccm.200506-859OC.
  • Romanello M, McGushin A, Di Napoli C, et al. The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future. Lancet. 2021;398(10311):1619–1662. doi:10.1016/S0140-6736(21)01787-6.
  • Eckelman MJ, Sherman JD, MacNeill AJ. Life cycle environmental emissions and health damages from the Canadian healthcare system: an economic-environmental-epidemiological analysis. PLoS Med. 2018;15(7):e1002623. doi:10.1371/journal.pmed.1002623.
  • Tennison I, Roschnik S, Ashby B, et al. Health care’s response to climate change: a carbon footprint assessment of the NHS in England. Lancet Planet Health. 2021;5(2):e84–e92. doi:10.1016/S2542-5196(20)30271-0.
  • Panigone S, Sandri F, Ferri R, Volpato A, Nudo E, Nicolini G. Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment. BMJ Open Resp Res. 2020;7(1):e000571. : doi:10.1136/bmjresp-2020-000571.
  • Janson C, Henderson R, Lofdahl M, Hedberg M, Sharma R, Wilkinson AJK. Carbon footprint impact of the choice of inhalers for asthma and COPD. Thorax. 2020;75(1):82–84. doi:10.1136/thoraxjnl-2019-213744.
  • Lavorini F, Corrigan CJ, Barnes PJ, et al. Retail sales of inhalation devices in European countries: so much for a global policy. Respir Med. 2011;105(7):1099–1103. doi:10.1016/j.rmed.2011.03.012.
  • van Hove M, Leng G. A more sustainable NHS. BMJ. 2019;366:l4930. doi:10.1136/bmj.l4930.
  • Hargreaves C, Budgen N, Whiting A, et al. S60 A new medical propellant HFO-1234ze(E): reducing the environmental impact of inhaled medicines. Thorax. 2022;77:A38.2–A39. doi:10.1136/thorax-2022-BTSabstracts.66.
  • Gupta S, Goodridge D, Pakhalé S, McIntyre K, Pendharkar S. Choosing wisely: The Canadian Thoracic Society’s list of six things that physicians and patients should question. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 2017;1(2):54–61. doi:10.1080/24745332.2017.1331666.
  • Canadian Thoracic Society. Seven Tests and Treatments to Question. Choosing Wisely Canada, Respiratory Medicine. Updated December 2022. Respiratory Medicine - Choosing Wisely Canada. https://choosingwiselycanada.org/recommendation/respiratory-medicine/. Accessed April 12, 2023.
  • Gershon AS, Victor JC, Guan J, Aaron SD, To T. Pulmonary function testing in the diagnosis of asthma: a population study. Chest. 2012;141(5):1190–1196. doi:10.1378/chest.11-0831.
  • Gershon AS, Hwee J, Croxford R, Aaron SD, To T. Patient and physician factors associated with pulmonary function testing for COPD: a population study. Chest. 2014;145(2):272–281. doi:10.1378/chest.13-0790.
  • Walters JA, Walters EH, Nelson M, et al. Factors associated with misdiagnosis of COPD in primary care. Prim Care Respir J. 2011;20(4):396–402. doi:10.4104/pcrj.2011.00039.
  • Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182(7):673–678. doi:10.1503/cmaj.091784.
  • Aaron SD, Vandemheen KL, FitzGerald JM, et al. Reevaluation of diagnosis in adults with physician-diagnosed asthma. JAMA. 2017;317(3):269–279. doi:10.1001/jama.2016.19627.
  • Gagne M, Karanikas A, Green S, Gupta S. Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis. BMJ Open Respiratory Research. 2023;10(1):e001716.
  • Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J. 2008;31(2):320–325. doi:10.1183/09031936.00039707.
  • Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest. 1991;99(4):837–841. [published Online First: 1991/04/01] doi:10.1378/chest.99.4.837.
  • Yang C, Hicks EA, Mitchell P, et al. Canadian Thoracic Society 2021 Guideline update: Diagnosis and management of asthma in preschoolers, children and adults. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 2021;5(6):348–361. doi:10.1080/24745332.2021.1945887.
  • Fan VS, Gylys-Colwell I, Locke E, et al. Overuse of short-acting beta-agonist bronchodilators in COPD during periods of clinical stability. Respir Med. 2016;116:100–106. [published Online First: 2016/06/15] doi:10.1016/j.rmed.2016.05.011.
  • Wilkinson A, Maslova E, Janson C, et al. Greenhouse gas emissions associated with asthma care in the UK: results from SABINA CARBON. European Respiratory Journal. 2021;58(suppl 65):OA76. doi:10.1183/13993003.congress-2021.OA76.
  • Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respiratory Medicine. 2011;105(6):930–938. 51. doi:10.1016/j.rmed.2011.01.005.
  • Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de- Sousa J. COPD: misuse of inhaler devices in clinical practice. COPD. 2019;14:1209–1217. doi:10.2147/COPD.S178040.
  • Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Respir J. 2002;19(2):246–251. doi:10.1183/09031936.02.00218402.
  • Melani AS, Zanchetta D, Barbato N, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol. 2004;93(5):439–446. doi:10.1016/s1081-1206(10)61410-x.
  • Volerman A, Carpenter D, Press VG. What can be done to impact respiratory inhaler misuse: exploring the problem, reasons, and solutions. Expert Rev Respir Med. 2020;14(8):791–805. doi:10.1080/17476348.2020.1754800.
  • Juntunen-Backman K, Kajosaari M, Laurikainen K, et al. Comparison of easyhaler metered-dose, dry powder inhaler and a pressurised metered-dose inhaler plus spacer in the treatment of asthma in children. Clin Drug Invest. 2002;22(12):827–835. doi:10.2165/00044011-200222120-00003.
  • Smith IJ, Parry-Billings M. The inhalers of the future? A review of dry powder devices on the market today. Pulmonary Pharmacology & Therapeutics. 2003;16(2):79–95. 5539(02)00147-5 doi:10.1016/S1094-.
  • Starup-Hansen J, Dunne H, Sadler J, Jones A, Okorie M. Climate change in healthcare: Exploring the potential role of inhaler prescribing. Pharmacol Res Perspect. 2020;8(6):e00675. doi:10.1002/prp2.675.
  • Müller V, Gálffy G, Eszes N, et al. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med. 2011;11(1):40. doi:10.1186/1471-2466-11-40.
  • Vanderman AJ, Moss JM, Bailey JC, Melnyk SD, Brown JN. Inhaler misuse in an older adult population. Consult Pharm. 2015;30(2):92–100. doi:10.4140/TCP.n.2015.92.
  • Al-Jahdali H, Ahmed A, Al-Harbi A, et al. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. All Asth Clin Immun. 2013;9(1):8. doi:10.1186/1710-1492-9-8.
  • Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. Journal of Allergy and Clinical Immunology. 2007;119(6):1537–1538. doi:10.1016/j.jaci.2007.02.037.
  • Martin MA, Catrambone CD, Kee RA, et al. Improving asthma self-efficacy: Developing and testing a pilot community-based asthma intervention for African American adults. J Allergy Clin Immunol. 2009;123(1):153–159.e3. doi:10.1016/j.jaci.2008.10.057.
  • Dekhuijzen PNR, Lavorini F, Usmani O. Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®. Patient Prefer Adherence. 2016;10:1561–1572. doi:10.2147/PPA.S82857.
  • Brocklebank D, Ram F, Wright J, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5(26):1–149. PMID: 11701099. doi:10.3310/hta5260.
  • Welch MJ, Nelson HS, Shapiro G, et al. Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. J Aerosol Med. 2004;17(2):129–139. PMID: 15294063. doi:10.1089/0894268041457174.
  • Gálffy G, Szilasi M, Tamási L. Clinical effectiveness, health-related quality of life and patient satisfaction after switch from metered dose inhaler to easyhaler dry powder inhaler in patients with asthma and COPD; a real-life study. Thorax. 2019;74:A212–A213.
  • Woodcock A, Janson C, Rees J, et al. Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis. Thorax. 2022;77(12):1187–1192. doi:10.1136/thoraxjnl-2021-218088.
  • Yang C, Hicks EA, Mitchell P, et al. 2021 Canadian Thoracic Society Guideline – A focused update on the management of very mild and mild asthma. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine. 2021;5(4):205–245. doi:10.1080/24745332.2021.1877043.
  • Wilkinson AJ, Braggins R, Steinbach I, Smith J. Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England. BMJ Open. 2019;9(10):e028763. doi:10.1136/bmjopen-2018-028763.
  • PrescQIPP Community Interest Company. Bulletin 295: inhaler carbon footprint. Attachment 1. https://www.prescqipp.info/our-resources/bulletins/bulletin-295-inhaler-carbon-footprint/.
  • Anderson P. Patient preference for and satisfaction with inhaler devices. European Respiratory Review. 2005;14(96):109–116. doi:10.1183/09059180.05.00009606.
  • Kaplan A, van Boven JFM. Switching inhalers: a practical approach to keep on UR RADAR. Pulm Ther. 2020;6(2):381–392. doi:10.1007/s41030-020-00133-6.
  • Busby J, Matthews JG, Chaudhuri R, et al. Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma. Eur Respir J. 2022;59(4):2100768. doi:10.1183/13993003.00768-2021.
  • Kponee-Shovein K, Marvel J, Ishikawa R, et al. Carbon footprint and associated costs of asthma exacerbation care among UK adults. J Med Econ. 2022;25(1):524–531. doi:10.1080/13696998.2022.2063603.
  • Clark AR, Weers JG, Dhand R. The confusing world of dry powder inhalers: it is all about inspiratory pressures, not inspiratory flow rates. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2020;33(1):1–11. doi:10.1089/jamp.2019.1556.
  • Brown PH, Ning AC, Greening AP, McLean A, Crompton GK. Peak inspiratory flow through Turbuhaler in acute asthma. Eur Respir J. 1995;8(11):1940–1941. doi:10.1183/09031936.95.08111940.
  • Engel T, Heinig JH, Madsen F, Nikander K. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). Eur Respir J. 1990;3(9):1037–1041. doi:10.1183/09031936.93.03091037.
  • Barbara s, Kritikos V, Bosnic-Anticevich S. Inhaler technique: does age matter? A systematic review. Eur Respir Rev. 2017;26(146):170055. doi:10.1183/16000617.0055-2017.
  • Lexmond AJ, Kruizinga TJ, Hagedoorn P, Rottier BL, Frijlink HW, de Boer AH. Effect of inhaler design variables on paediatric use of dry powder inhalers. PLoS One. 2014;9(6):e99304. doi:10.1371/journal.pone.0099304.
  • Health Products Stewardship Association. Returning Medications. https://healthsteward.ca/consumers/returning-medications. Accessed April 12, 2023.
  • Government of Canada. Authorizations for ozone-depleting substances and hydrofluorocarbons. https://www.canada.ca/en/environment-climate-change/services/canadian-environmental-protection-act-registry/permits/authorizations-ozone-depleting-substances.html. Accessed April 12, 2023.
  • Government of Canada – Justice Laws Website. Ozone-depleting substances and halocarbon alternatives regulations. https://laws-lois.justice.gc.ca/eng/regulations/SOR-2016-137/FullText.html?txthl=allowance. Accessed April 12, 2023.
  • Eur-Lex. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on fluorinated greenhouse gases, amending Directive (EU) 2019/1937 and repealing Regulation (EU) No 517/2014. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52022PC0150. Accessed April 12, 2023.
  • United States Environmental Protection Agency. HFC Allowance Allocations. Accessed at: https://www.epa.gov/climate-hfcs-reduction/hfc-allowance-allocations. Accessed April 12, 2023.
  • British Thoracic Society. SIGN 158: British guideline on the management of asthma: A national clinic guideline. sign158-updated.pdf. First published 2003, revised edition published 2019. Accessed April 12, 2023.
  • European Respiratory Society. European Respiratory Society position statement on asthma and the environment. May 5, 2021. https://www.ersnet.org/news-and-features/news/ers-publishes-position-statement-asthma-environment/. Accessed online April 12, 2023.
  • NICE patient decision aid reference: Asthma inhalers and climate change. NICE/BTS/SIGN. 2022. NG80 Asthma inhalers and the environment patient decision aid (nice.org.uk). Accessed April 12, 2023.
  • The Intergovernmental Panel on Climate Change. AR6 Synthesis Report – Climate Change 2023. https://www.ipcc.ch/report/ar6/syr/. Accessed April 12, 2023.
  • Woodcock A, Beeh KM, Sagara H, et al. The environmental impact of inhaled therapy: making informed treatment choices. Eur Respir J. 2022;60(1):2102106. doi:10.1183/13993003.02106-2021.

CTS Choosing Wisely References

  • British Thoracic Society. SIGN 158: British guideline on the management of asthma: A national clinic guideline. First published 2003, revised edition published 2019. Accessed at: sign158-updated.pdf. Accessed April 12, 2023.
  • Canadian Thoracic Society. Respiratory medicine: seven tests and treatments to question. Choosing Wisely Canada, last updated December 2022. Available at: https://choosingwiselycanada.org/recommendation/respiratory-medicine/
  • Haidl P, Heindl S, Siemon K, Bernacka M, Cloes RM. Inhalation device requirements for patients’ inhalation maneuvers. Respiratory Medicine. 2016;118:65–75. doi:10.1016/j.rmed.2016.07.013.
  • Keeley D, Scullion JE, Usmani OS. Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers. Eur Respir J. 2020;55(2):2000048. doi:10.1183/13993003.00048-2020.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.